Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs

Fabrizio Fabris; Maria Luigia Randi; Maria Elena Crociani; Sergio Manzoni; Paolo Tonin; Luciano De Zanche; Giuseppe Cella; Antonio Girolami

doi:10.1007/BF02906924

Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs

Fabrizio Fabris, Maria Luigia Randi, Maria Elena Crociani, Sergio Manzoni, Paolo Tonin, Luciano De Zanche, Giuseppe Cella, Antonio Girolami

Istituto di Neuroriabilitazione Motoria San Camillo

Research output: Contribution to journal › Article › peer-review

Abstract

Levels of β-thromboglobulin and platelet factor 4 in 46 patients with transient ischemic attacks and the influence of treatment with dipyridamole or aspirin plus dipyridamole were evaluated. Patients not receiving therapy showed levels of β-thromboglobulin significantly higher than controls. However, patients taking only dipyridamole showed values of β-thromboglobulin significantly lower than untreated patients or those taking aspirin plus dipyridamole. No significant difference was observed with regard to platelet factor 4 between the patients.

Original language	English
Pages (from-to)	437-442
Number of pages	6
Journal	La Ricerca in Clinica e in Laboratorio
Volume	13
Issue number	4
DOIs	https://doi.org/10.1007/BF02906924
Publication status	Published - Oct 1983

Keywords

β-thromboglobulin
Anti-platelet drugs
Aspirin
Dipyridamole
Platelet factor 4
Platelet-specific proteins
Transient ischemic attacks

ASJC Scopus subject areas

Clinical Biochemistry

Access to Document

10.1007/BF02906924

Cite this

@article{5e49dbef82814f67a601628205e7c47e,

title = "Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs",

abstract = "Levels of β-thromboglobulin and platelet factor 4 in 46 patients with transient ischemic attacks and the influence of treatment with dipyridamole or aspirin plus dipyridamole were evaluated. Patients not receiving therapy showed levels of β-thromboglobulin significantly higher than controls. However, patients taking only dipyridamole showed values of β-thromboglobulin significantly lower than untreated patients or those taking aspirin plus dipyridamole. No significant difference was observed with regard to platelet factor 4 between the patients.",

keywords = "β-thromboglobulin, Anti-platelet drugs, Aspirin, Dipyridamole, Platelet factor 4, Platelet-specific proteins, Transient ischemic attacks",

author = "Fabrizio Fabris and Randi, {Maria Luigia} and Crociani, {Maria Elena} and Sergio Manzoni and Paolo Tonin and {De Zanche}, Luciano and Giuseppe Cella and Antonio Girolami",

year = "1983",

month = oct,

doi = "10.1007/BF02906924",

language = "English",

volume = "13",

pages = "437--442",

journal = "Ricerca in Clinica e in Laboratorio",

issn = "0940-5437",

publisher = "Springer Verlag",

number = "4",

}

TY - JOUR

T1 - Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs

AU - Fabris, Fabrizio

AU - Randi, Maria Luigia

AU - Crociani, Maria Elena

AU - Manzoni, Sergio

AU - Tonin, Paolo

AU - De Zanche, Luciano

AU - Cella, Giuseppe

AU - Girolami, Antonio

PY - 1983/10

Y1 - 1983/10

N2 - Levels of β-thromboglobulin and platelet factor 4 in 46 patients with transient ischemic attacks and the influence of treatment with dipyridamole or aspirin plus dipyridamole were evaluated. Patients not receiving therapy showed levels of β-thromboglobulin significantly higher than controls. However, patients taking only dipyridamole showed values of β-thromboglobulin significantly lower than untreated patients or those taking aspirin plus dipyridamole. No significant difference was observed with regard to platelet factor 4 between the patients.

AB - Levels of β-thromboglobulin and platelet factor 4 in 46 patients with transient ischemic attacks and the influence of treatment with dipyridamole or aspirin plus dipyridamole were evaluated. Patients not receiving therapy showed levels of β-thromboglobulin significantly higher than controls. However, patients taking only dipyridamole showed values of β-thromboglobulin significantly lower than untreated patients or those taking aspirin plus dipyridamole. No significant difference was observed with regard to platelet factor 4 between the patients.

KW - β-thromboglobulin

KW - Anti-platelet drugs

KW - Aspirin

KW - Dipyridamole

KW - Platelet factor 4

KW - Platelet-specific proteins

KW - Transient ischemic attacks

UR - http://www.scopus.com/inward/record.url?scp=0021074396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021074396&partnerID=8YFLogxK

U2 - 10.1007/BF02906924

DO - 10.1007/BF02906924

M3 - Article

C2 - 6197742

AN - SCOPUS:0021074396

VL - 13

SP - 437

EP - 442

JO - Ricerca in Clinica e in Laboratorio

JF - Ricerca in Clinica e in Laboratorio

SN - 0940-5437

IS - 4

ER -

Platelet-specific proteins in patients with transient ischemic attacks - Effects of anti-platelet drugs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this